BACKGROUND: Recent studies of anesthetic-induced unconsciousness in humans have focused predominantly on the intravenous drug propofol and have identified anterior dominance of alpha rhythms and frontal phase-amplitude coupling patterns as neurophysiological markers. However, it is unclear whether the correlates of propofol-induced unconsciousness are generalizable to inhaled anesthetics, which have distinct molecular targets and which are used more commonly in clinical practice. METHODS: The authors recorded 64-channel electroencephalograms in healthy human participants during consciousness, sevoflurane-induced unconsciousness, and recovery (n = 10; n = 7 suitable for analysis). Spectrograms and scalp distributions of low-frequency (1 Hz) and alpha (10 Hz) power were analyzed, and phase-amplitude modulation between these two frequencies was calculated in frontal and parietal regions. Phase lag index was used to assess phase relationships across the cortex. RESULTS: At concentrations sufficient for unconsciousness, sevoflurane did not result in a consistent anteriorization of alpha power; the relationship between low-frequency phase and alpha amplitude in the frontal cortex did not undergo characteristic transitions. By contrast, there was significant cross-frequency coupling in the parietal region during consciousness that was not observed after loss of consciousness. Furthermore, a reversible disruption of anterior-posterior phase relationships in the alpha bandwidth was identified as a correlate of sevoflurane-induced unconsciousness. CONCLUSION: In humans, sevoflurane-induced unconsciousness is not correlated with anteriorization of alpha and related cross-frequency patterns, but rather by a disruption of phase-amplitude coupling in the parietal region and phase-phase relationships across the cortex.
BACKGROUND: Recent studies of anesthetic-induced unconsciousness in humans have focused predominantly on the intravenous drug propofol and have identified anterior dominance of alpha rhythms and frontal phase-amplitude coupling patterns as neurophysiological markers. However, it is unclear whether the correlates of propofol-induced unconsciousness are generalizable to inhaled anesthetics, which have distinct molecular targets and which are used more commonly in clinical practice. METHODS: The authors recorded 64-channel electroencephalograms in healthy humanparticipants during consciousness, sevoflurane-induced unconsciousness, and recovery (n = 10; n = 7 suitable for analysis). Spectrograms and scalp distributions of low-frequency (1 Hz) and alpha (10 Hz) power were analyzed, and phase-amplitude modulation between these two frequencies was calculated in frontal and parietal regions. Phase lag index was used to assess phase relationships across the cortex. RESULTS: At concentrations sufficient for unconsciousness, sevoflurane did not result in a consistent anteriorization of alpha power; the relationship between low-frequency phase and alpha amplitude in the frontal cortex did not undergo characteristic transitions. By contrast, there was significant cross-frequency coupling in the parietal region during consciousness that was not observed after loss of consciousness. Furthermore, a reversible disruption of anterior-posterior phase relationships in the alpha bandwidth was identified as a correlate of sevoflurane-induced unconsciousness. CONCLUSION: In humans, sevoflurane-induced unconsciousness is not correlated with anteriorization of alpha and related cross-frequency patterns, but rather by a disruption of phase-amplitude coupling in the parietal region and phase-phase relationships across the cortex.
Authors: R T Canolty; E Edwards; S S Dalal; M Soltani; S S Nagarajan; H E Kirsch; M S Berger; N M Barbaro; R T Knight Journal: Science Date: 2006-09-15 Impact factor: 47.728
Authors: Laura D Lewis; Veronica S Weiner; Eran A Mukamel; Jacob A Donoghue; Emad N Eskandar; Joseph R Madsen; William S Anderson; Leigh R Hochberg; Sydney S Cash; Emery N Brown; Patrick L Purdon Journal: Proc Natl Acad Sci U S A Date: 2012-11-05 Impact factor: 11.205
Authors: George A Mashour; Amy Shanks; Kevin K Tremper; Sachin Kheterpal; Christopher R Turner; Satya Krishna Ramachandran; Paul Picton; Christa Schueller; Michelle Morris; John C Vandervest; Nan Lin; Michael S Avidan Journal: Anesthesiology Date: 2012-10 Impact factor: 7.892
Authors: Thomas Thiery; Tarek Lajnef; Etienne Combrisson; Arthur Dehgan; Pierre Rainville; George A Mashour; Stefanie Blain-Moraes; Karim Jerbi Journal: Neuroimage Date: 2018-06-07 Impact factor: 6.556
Authors: O Akeju; K J Pavone; J A Thum; P G Firth; M B Westover; M Puglia; E S Shank; E N Brown; P L Purdon Journal: Br J Anaesth Date: 2015-07 Impact factor: 9.166
Authors: Phillip E Vlisides; Tarik Bel-Bahar; UnCheol Lee; Duan Li; Hyoungkyu Kim; Ellen Janke; Vijay Tarnal; Adrian B Pichurko; Amy M McKinney; Bryan S Kunkler; Paul Picton; George A Mashour Journal: Anesthesiology Date: 2017-07 Impact factor: 7.892
Authors: Joel P Baumgart; Zhen-Yu Zhou; Masato Hara; Daniel C Cook; Michael B Hoppa; Timothy A Ryan; Hugh C Hemmings Journal: Proc Natl Acad Sci U S A Date: 2015-09-08 Impact factor: 11.205
Authors: Andreas Ranft; Daniel Golkowski; Tobias Kiel; Valentin Riedl; Philipp Kohl; Guido Rohrer; Joachim Pientka; Sebastian Berger; Alexander Thul; Max Maurer; Christine Preibisch; Claus Zimmer; George A Mashour; Eberhard F Kochs; Denis Jordan; Rüdiger Ilg Journal: Anesthesiology Date: 2016-11 Impact factor: 7.892
Authors: Matthew I Banks; Bryan M Krause; Christopher M Endemann; Declan I Campbell; Christopher K Kovach; Mark Eric Dyken; Hiroto Kawasaki; Kirill V Nourski Journal: Neuroimage Date: 2020-02-08 Impact factor: 6.556